Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prosp (Q51089741)
Jump to navigation
Jump to search
scientific article published in May 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prosp |
scientific article published in May 2014 |
Statements
Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prosp (English)
1 reference
S R Solomon
1 reference
C A Sizemore
1 reference
X Zhang
1 reference
S Brown
1 reference
H K Holland
1 reference
L E Morris
1 reference
A Bashey
1 reference
1 May 2014
1 reference
49
1 reference
5
1 reference
616-621
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference